FindTrial
Sign In

The modified Dixon sequential test method was used to determine the effective dose of oselidine fumarate injection combined with propofol in painless gastroscopy

The modified Dixon sequential test method was used to determine the effective dose of oselidine fumarate injection combined with propofol in painless gastroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093609
Enrollment
Unknown
Registered
2024-12-09
Start date
2024-12-15
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric disease

Interventions

Male group:Oliceridine combined with propofol
Female group:Oliceridine combined with propofol

Sponsors

Shaanxi 215 Hospital of nuclear industry
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1.18-64 years old; 2.BMI: 18.5-29.9kg/?; 3.ASA level I~II; 4.Patients undergoing painless gastroscopy.

Exclusion criteria

Exclusion criteria: 1.Patients with severe heart, brain, lung, liver, and kidney diseases; 2.Patients with known anesthetic drugs in the past, or allergic to drug-related ingredients; 3.Patients undergoing special treatment under gastroscopy;

Design outcomes

Primary

MeasureTime frame
Incidence of positive reaction during implanting gastroscope;—

Secondary

MeasureTime frame
Vital signs;Baseline;Adverse reaction;Other indicators;—

Countries

China

Contacts

Public ContactLiuqin Jiang

Shaanxi 215 Hospital of nuclear industry

jlq215hp@163.com+86 29 32088348

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026